University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
5-2021

Role of KVβ2
KV 2 subunits in regulation of resistance arterial tone.
Sean M Raph
University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Cardiovascular System Commons

Recommended Citation
Raph, Sean M, "Role of KVβ2 subunits in regulation of resistance arterial tone." (2021). Electronic Theses
and Dissertations. Paper 3589.
https://doi.org/10.18297/etd/3589

This Master's Thesis is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of
the author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

ROLE OF KVβ2 SUBUNITS IN REGULATION OF RESISTANCE
ARTERIAL TONE

By
Sean M. Raph
B.A., University of Maine at Farmington, 2012
M.Bio.Sci., University of Southern Maine, 2015

A Thesis
Submitted to the Faculty of the
School of Medicine of the University of Louisville
In Partial Fulfillment of the Requirements
For the Degree of

Master of Science
in Pharmacology and Toxicology

Department of Pharmacology and Toxicology
University of Louisville
Louisville, KY

May 2021

ROLE OF KVβ2 SUBUNITS IN REGULATION OF
RESISTANCE ARTERIAL TONE
By
Sean M. Raph
B.A., University of Maine at Farmington, 2012
M.Bio.Sci., University of Southern Maine, 2015

Thesis Approved on

November 18th, 2020
by the following Thesis Committee:

Matthew A. Nystoriak, Ph.D.

Aruni Bhatnagar, Ph.D.

Zhao-hui Song, Ph.D.

Steven P. Jones, Ph.D.
Bradford Hill, Ph.D.

Amanda Jo LeBlanc, Ph.D.

ii

DEDICATION

This thesis is dedicated to my parents Stephen M.
Raph and Elizabeth J. Sylvester who have always
supported and encouraged me to forge my own path.

iii

ACKNOWLEDGEMENTS
I would like to thank my mentor Dr. Matthew Nystoriak, for
his guidance, leadership, and patience. I would also like to
thank my committee members, Drs. Bhatnagar, Jones,
Song, Hill, and LeBlanc. I would also like to convey my
thanks and love to my wife Sara Jane, and our children
Kieran and Ronan, for their love, support, and understanding
through long hours and frustrating months, and allowing me
to frequently practice patience.

iv

ABSTRACT
ROLE OF KVβ2 SUBUNITS IN REGULATION OF
RESISTANCE ARTERIAL TONE
Sean M. Raph
November 18th, 2020

Voltage-gated potassium (Kv) channels control vascular resistance and facilitate
the augmentation of myocardial blood flow in response to increases in cardiac workload
(i.e., metabolic hyperemia). Native sarcolemmal Kv1 channels in arterial myocytes
associate with a heteromeric auxiliary complex consisting of intracellular Kvβ1 and Kvβ2
proteins. The Kvβ proteins differentially regulate the function of heterologously expressed
Kv channels, as well as native Kv1 channels in excitable cells of the cardiovascular and
nervous systems. The physiological importance of vascular Kvβ proteins in mediating
vasodilation remains unknown. In this study, I tested the hypothesis that Kvβ proteins
functionally regulate vascular tone in response to an altered pyridine nucleotide redox
state. I evaluated ex vivo vasoreactivity of small diameter mesenteric arteries isolated from
wild type (WT), mutant mice in which either Kv channel subfamily a member regulatory
beta subunits 1 or 2 (Kcnab1 or Kcnab2, respectively) was deleted (i.e., Kvβ1.1-/- and
Kvβ2-/-, respectively), transgenic mice in which kcnab1.1 overexpression was induced by
addition of doxycycline to the water (SM22α-rtTA: TRE β1) and point mutant mice in which
the Kvβ2 subunit was catalytically inactive (Kvβ2Y90F). Loss of Kvβ1.1 or Kvβ2 did not
significantly impact vasoconstriction in response to elevated extracellular K+ (60 mM),
v

U46619 (thromboxane A2 analogue), or increases in intravascular pressure. Whereas
vasodilation in response to application of adenosine (10-6 – 10-4 M) was similar between
Kvβ-null and WT groups, vasodilation in response to external L-lactate (5-20 mM), which
modifies cellular pyridine nucleotide redox state , was sensitive to inhibition by the Kv1selective inhibitor psora-4 (500 nM) and was abolished in arteries from Kvβ2-/- mice but
not in arteries from Kvβ1-/- mice. Interestingly, arteries from mice in which overexpression
of the Kvβ1 subunit (SM22α-rtTA: TRE β1) and point-mutated inactivation of Kvβ2
(Kvβ2Y90F) enzymatic function, similarly abolished vasodilation in response to external Llactate (5-20 mM). Our results indicate that vascular tone is differentially regulated by Kv1associated Kvβ proteins, whereby Kvβ2 promotes and Kvβ1.1 opposes lactate induced
vasodilation. Additionally, our data signify the importance of the Kvβ-subunit complex
composition and enzymatic function in promoting vasodilation in response to an altered
pyridine nucleotide redox state.
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LITERATURE REVIEW

a. Introduction
Adequate blood flow requires an adaptive, dynamic system, capable of matching
oxygen and nutrient supply to organ metabolic demand.1 Small resistance arteries (~100300 µm)
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contractile state is modified to alter blood flow and prevent tissue ischemia

during increased metabolic activity. Disruptions in blood flow can result in ischemic injury
and organ failure that increases the risk of morbidity and death.3,4 The intricate
mechanisms underlying metabolic regulation of blood flow are poorly understood.
The concentration of vascular smooth muscle global cytosolic free Ca2+ ([Ca2+]i
regulates arterial tone. In the vascular smooth muscle cell, [Ca2+]i is predominantly
determined by sarcolemmal membrane potential and Ca2+ influx via L-type voltagedependent Ca2+ channels (VDCC).5 This literature review will discuss the major known
mechanisms of arterial tone regulation. Part one of this review will discuss vascular
smooth muscle mediated arterial tone regulation, focusing on mechanisms of ion channel
mediated vascular tone regulation. Part two will discuss the biochemical and physiological
properties of K+ channel associated AKR6A (KVβ) proteins. This literature review will
provide the base evidence for investigating the role of KVβ proteins in regulating arterial
tone. a

a

Parts of the following thesis have been previously published with Sean Raph listed as co-first author or first author, respectively; 6
Ohanyan, V. et al. Myocardial Blood Flow Control by Oxygen Sensing Vascular Kvbeta Proteins. Circ Res,
doi:10.1161/CIRCRESAHA.120.317715 (2021); 7
Raph, S. M., Bhatnagar, A. & Nystoriak, M. A. Biochemical and physiological
properties of K(+) channel-associated AKR6A (Kvbeta) proteins. Chem Biol Interact 305, 21-27, doi:10.1016/j.cbi.2019.03.023 (2019).
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b. Part 1: Resistance artery physiology
Resistance Artery Myogenic Tone Regulation
Resistance arteries are those arteries with a diameter in the range of ~100-300
µm.8 These small resistance arteries exhibit a large dynamic range of arterial distention
and significantly influence blood pressure and flow. Adequate supply of blood flow to
organs requires arteries that can adequately dilate in response to the metabolic demand
of the supplied organs and tissues. To allow for adequate O2 and nutrient supply, the
resistance arteries must allow for greater blood flow. This is achieved in one of two ways;
1) the heart can pump harder, forcing a greater volume of blood through the same
diameter ‘tube’ in turn increasing the pressure in the circulatory system, however this will
further exacerbate the O2 deficit of the heart and therefore is insufficient; or 2) the artery
can dilate, increasing the diameter of the vessel through which a greater of volume of
blood can travel. In those events where the heart does pump more blood but small
resistance arterial dilation is impaired, the tissue becomes starved of oxygen and
nutrients.9 To match organ blood flow demands, the vascular smooth muscle mediate
vasoconstriction through a response known as myogenic tone. This is achieved through
tight regulation of intracellular [Ca2+]i. For example, influx of Ca2+ induces vasoconstriction
(decreased diameter), while inhibition of Ca2+ influx induces vasodilation (increased
diameter).10 Calcium enters the vascular smooth muscle cells via L-type voltagedependent Ca2+ channels (VDCC), which will be discussed in greater detail later.

Control of blood flow
The movement of blood through the circulatory system is dependent on regions of
variable pressure. Blood moves from regions of high pressure (i.e., aorta) to regions of
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low pressure (i.e., capillaries). The increase in blood flow parallels this increase in
pressure (ΔP); however, resistance opposes blood flow. Blood flow is proportional to ΔP
and inversely proportional to vascular resistance (R) such that: Flow≈ ΔP/R. Furthermore,
resistance is a function of length (L) and radius (r) of the vessel and viscosity (η) of the
fluid moving through the vessel and are best expressed by Poiseuille’s Law: R = 8Lη/πr4.
Because the circulatory system and blood viscosity are generally constant, the equation
can be refined to the following: R ≈ 1/r4. Therefore, this equation declares that vascular
resistance is inversely proportional to the vessel radius to the fourth power. For example,
a change of arterial diameter from 100 µm to 80 µm will result in ~59% reduction in blood
flow. For example during hyperemia, a regulatory process by which blood flow is modified
to match changes in metabolic and oxygen demand and prevent ischemia, significant
changes in arterial diameter are necessary to prevent end organ damage.11 There are
several situational hyperemia responses; 1) reactive, the response to diminished tissue
oxygen and increased metabolic waste (ischemia), 2) active, a response to increased
exertion (i.e., exercise), and 3) infectious or traumatic, as during infection of a cut or
edema.11 To match these increased demands of the tissues (i.e., brain, skeletal muscle,
heart) small resistance arteries must dilate. The KV channels play an important role in
regulating vascular tone during hyperemia.12 This reaffirms that arterial diameter is a
significant driving force of vascular resistance and even small changes can have
significant effects on blood flow and end organ perfusion.

Autoregulation and Ca2+ dependence of vascular tone
Maintaining constant blood flow during changes in blood pressure requires
resistance vasculature to constrict in response to increased intravascular pressure and
dilate in response to reduced pressure. This phenomenon of arterial constriction in

3

response to increased intravascular pressure, or “myogenic tone” was first described by
Bayliss in the early 1900’s.13 These constrictions resulting from increases in intravascular
pressure were later identified to be an intrinsic characteristic of arterial wall smooth muscle
cells independent of other influences (e.g., endothelial).14-16 Additionally, increasing
intravascular pressure to within the physiological range (60-100 mmHg) results in
membrane depolarization of vascular smooth muscle cells and activation of voltage
dependent Ca2+ channels (VDCC), which results in an increase in [Ca2+]i, vascular smooth
muscle contraction, and vessel constriction.17-19 The effects of pressure and other
endogenous mediators of arterial tone are significant for regulating a partially constricted
state in order to match blood flow to metabolic demand in small diameter arteries.20,21
These various factors (e.g., pressure) contribute to the autoregulation of vascular tone.

Regulation of smooth muscle membrane potential
The activity of VDCCs and smooth muscle [Ca2+]i is dependent on the membrane
potential. The change in membrane potential of vascular smooth muscle cells and [Ca2+]i
mediated constriction is tightly regulated and is modified by efflux of potassium ions (K+).
The intracellular and extracellular K+ concentrations, determined by the high permeability
of the cell membrane and chemical gradient for K+ ions, drive the resting membrane
potential. This is due to the differing intracellular (~140 mM) and extracellular (~4-6 mM)
K+ concentrations. However, when the cell membrane becomes depolarized, voltage
gated potassium channels open to drive hyperpolarization and return to the EK Nernst
potential. This efflux of K+ diminishes positive charge increasing the electrical driving force
inward toward the cytoplasm. A major family of K+-selective channels regulates vascular
smooth muscle cell membrane potential. This section will first describe how regulation of
ion flow affects membrane potential and then will describe the properties of K+ channels
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that are expressed in small resistance arteries: voltage dependent (KV), large conductance
Ca2+ activated (BK), ATP-sensitive (KATP), and inwardly rectifying (KIR) K+ channels.

Membrane polarization of excitable cells: The polarization state of excitable cells (e.g.
neurons) depends on the flow of positively and negatively charged ions, predominantly
this includes K+, Na+, and Cl-.22 The movement of ions across the membrane is determined
by their respective electrical and chemical gradients. When the electrical forces driving
ions into or out of the cell matches the chemical forces driving ions into or out of the cell,
this determines the membrane potential at which there is no net flow of that ion in either
direction across the membrane, this is known as the equilibrium potential. The equilibrium
potential for each respective ion (X) can be calculated using the Nernst Equation,
EX = (RT/zF)*ln([X]O/[X]i)
where R is the gas constant, T is temperature, z is the charge of the ion, F is the Faraday
constant, and [X]O, [X]i are the external and internal ion concentrations (mM). Further
simplified, this can be written as
EX = 58 mV/1*log([X]O/[X]i)
Using this we can calculate the equilibrium potential (EK) for K+, to be approximately -90
mV, when [K+]O = ~4.7 and [K+]I = 150.19 These equations are used to determine the
contributions of the different ions to the resting membrane potential. By using the Goldman
equation,23 Hodgkin and Huxley analyzed the respective contributions of ions to
membrane potential of the squid giant axon.24-26 They observed that K+ had the greatest
contribution to the resting membrane potential. Furthermore, the resting membrane
potential for many excitable cells is driven by EK (~90 mV) meaning the membrane is most
permeable to potassium. Since Hodgkin, Huxley, and Katz established that membrane
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excitability is largely maintained by K+ channels27-31, numerous investigations have found
numerous K+ specific channels32, which regulate a multitude of different physiological
processes.33-35

Inwardly rectifying channels: Inwardly rectifying (KIR) channels have evolved voltage
independent mechanisms of activation such as gating by G-proteins, pH, and ATP. Unlike
other K+ channels (e.g. KV) the KIR are comprised of two membrane spanning helices.36
Additionally, these channels more readily pass K+ ions inward than outward when
membrane potential is negative to EK; however, arterial myocyte membrane potential is
positive to EK and currents through these KIR channels is low. Hyperpolarization occurs
when external K+ is elevated and K+ efflux through KIR occurs.37 Additionally, KIR may by
activated by cellular release of K+ during hypoxia and ischemia.38 As a result, K+-induced
dilation during reduced oxygen and nutrient delivery in metabolically active cells is a result
of KIR and may be an important mechanism to increase blood flow and prevent ischemia.

ATP inactivates the ATP-sensitive potassium channels: The inward rectifying ATPsensitive potassium channels (KATP) are inhibited when the intracellular ATP:ADP ratio
increases. The KATP channels are comprised of pore-forming subunits and sulfonylurea
receptor subunits. This gives rise to the sensitivity of KATP channels to sulfonylurea
inhibitors like glibenclamide.39 Activation of KATP channels mediates vasodilation via the
sulfonylurea receptor subunits and adenosine A2 receptor.40 ATP hydrolysis produces
adenosine, this binds to adenosine type 2A receptors, a G-coupled protein which
stimulates adenylate cyclase and increases cyclic-AMP.41 Through this mechanism, KATP
channels are activated, hyperpolarizing the cell membrane, inhibiting VDCC mediated
Ca2+ influx and inducing vasodilation.41 As adenosine is a product of increased metabolic
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activity, KATP channels are included in the growing list of modifiers of blood flow; however,
recent reviews provide collected evidence that KATP channels may not be key mediators
of coronary vasodilation in response to exercise.2,42-45

Large conductance Ca2+ activated potassium channels: The large conductance Ca2+
activated potassium channels (BK) are comprised of four α-subunits, which form an ion
conducting pore and associated β subunits. Genetic ablation (i.e. BK-/-) and or
pharmacological inhibition of BK channels induces constriction and greater myogenic
tone, thus reducing blood flow in BK-/- mice as compared with wildtype.46-48 The BK
channels mediate K+ efflux in response to local release of sarcoplasmic reticulum Ca2+ by
ryanodine receptor mediated calcium sparks.49-52 The BK-mediated efflux of K+ drives
membrane hyperpolarization, which inhibits VDCC facilitated Ca2+ influx and induces
vasodilation.49 The release of sarcoplasmic intracellular Ca2+ mediated by ryanodine
receptors, which in turn activate BK channels signify yet another important mechanism
that regulates blood flow.

Voltage dependent K+ channels: The voltage dependent potassium (KV) channels are
comprised of ~35 genes that can be further categorized into 12 families expressed in
excitable cells. There are several KV channels expressed in small resistance arteries
including members of the KV1, KV2 and KV7 families.53 The KV channels are comprised of
a heteromeric pore formed by KVα-subunits, which consist of six transmembrane helices
(S1-S6) with S5-S6 forming the ion conducting pore and S4 containing the voltage sensor
region.53 Additionally, the KVα complex associates with intracellular β-subunit complex,
which binds the α-subunit at the intracellular T1 region. The β-subunits bind endogenous
cofactors and substrates, which modify KVα channel activity. KV channels play a significant
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role in mediating vasodilatory control in response to altered metabolic demand.54 There is
significant evidence that functional KV channels are crucial in regulating arterial tone.19,55
Additionally, KV channels are crucial to modifying coronary blood flow in mice56, and play
a role in adaptive and innate immune cell development57, neuronal diseases such as
epilepsy58, and sleep59, and hyperpolarization of excitable cells.60

Endothelial influences
Since the discovery of the endothelium in the late 1800’s, it has been perceived as
an entity separate and inert from other segments of the vasculature. However, the
mechanisms of endothelial regulation of vascular function have been intently investigated.
This section will provide an overview of several major endothelial originating factors that
influence vasodilation, including nitric oxide (NO), endothelium derived relaxing factor
(EDRF), and endothelin-1 (ET-1).

Nitric oxide: Nitric oxide (NO) plays an important role in regulating vascular tone.61,62
Acetylcholine, first isolated and synthesized in the 19th century by Adolf von Baeyer and
later by Dudley and others63,64, stimulates vasodilation via increased nitric oxide synthase
(NOS).65 The effect of acetylcholine induced vasorelaxation was first recognized by Mott
and Halliburton in the early 1900’s, when small concentrations decreased blood pressure
in laboratory animals.66 Decades later, a functional role for the endothelium was observed
when Furchgott and Zawadski directly noted acetylcholine induced smooth muscle
relaxation.67 It was not until 1987 when, separately, Ignarro68,69 and Palmer70,
independently identified nitric oxide (NO) as the mediating factor. After these influential
discoveries, several ligands were identified (e.g., bradykinin, acetylcholine) which bind to
endothelial receptors and mediate a cascade that initiates activation of enzymes in the
8

nitric oxide synthase (NOS) pathway. Both agonists and sheer stress induce increased
production of endothelial NO.71,72 Due to either endothelial agonist or sheer stress
stimulation of the NOS enzymatic machinery converts L-arginine to L-citrulline and NO is
produced as a byproduct.73 NO then diffuses from endothelial cells to vascular smooth
muscle cells where NO activates soluble guanylate cyclase (sGC), which increases cyclic
guanosine monophosphate (cGMP) production.74 Elevated cGMP activates PKG, which
inhibits IP3R mediated sarcoplasmic Ca2+ release, this decreases intracellular Ca2+, and
results in vasorelaxation.74,75 However, there are other mechanisms of vasodilation
discussed in great detail in these reviews.76-78 Additionally, NO plays a role in numerous
other mechanisms such as, angiogenesis79, apoptosis73, neurotransmission, inflammation
response, and thrombosis.80 Although NO has been proposed as a key mediator of
coronary vasodilation several studies have shown that blockade of NO does not
significantly influence coronary dilation in response to increased cardiac work (i.e.
exercise).72,81 It has also been shown that blockade of NOS has a negligible effect on
metabolic coronary vasodilation during exercise.8,81-83 It has been proposed that
endothelial mediated control acts to preserve a reserve dilatory capacity in order to
prevent excessive shear stress.8,84

Endothelial derived relaxing factors: There have been numerous endothelial derived
relaxing factors (EDRF) identified, including ADP, CGRP, thrombin, P450 metabolites of
arachidonic acid, H2S, and H2O2.85-87 EDRF molecules activate soluble guanylate cyclase,
this increases cyclic-GMP (c-GMP) in the vascular smooth muscle. NO binds to soluble cGMP and starts a signaling cascade that drives vasorelaxation (described in further detail
above in “Nitric oxide”). These EDRF molecules exact local or direct change to vascular
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tone in response to changes in metabolic demand.88 This is further evidence of a
multifaceted compensatory mechanism to ensure proper blood flow regulation.89

Endothelin-1: The vasoconstrictor endothelin (ET) is expressed as three isoforms, though
endothelial cells express only ET-1. The precursor to ET-1, Big ET-1, is converted to ET1 by endothelin converting enzyme.90 Receptors for ET-1 have been identified in both
vascular smooth muscle and endothelial cells and distribution of different receptors is
dependent on the type of vascular bed. Extracellular Ca2+ enters the cells when ET-1 binds
ETA or ETB2 receptors; however, the ETB1 receptor is also linked to NO- and PGI2-mediated
vasodilation.75 ET-1 increases the sensitivity of myosin light chain (MLC) to Ca2+, inducing
vasoconstriction.91 Additionally, ET-1 induced Ca2+ increase is inhibited by nicardipine,
and vasoconstriction is inhibited by the inhibitor of the ETA receptor BQ-123, but not the
ETB agonist IRL 1620.91 The ET-1-induced constriction is impaired by either BQ-123 or
GDPβS in the presence of increased Ca2+.91 Additionally, there is evidence supporting a
role for ET-1 in the development of vascular diseases in which blood flow is impaired.92
Despite being an essential regulator of vascular tone, high levels of ET-1 contribute to
enhancement of hypoxia induced hypertension via inhibition of KCa channel
conductance.93 Importantly, ET-1 at low concentrations increases KCa activity, but in
excess of 5 nM, ET-1 inhibits KCa conductance.93 Importantly, high levels of ET-1 mediated
vasomotor control can detrimentally contribute to dysregulated blood flow.

Taken together, these different pathways act as complements to one another in
regulation of arterial tone and therefore blood flow. It is crucial to remember that no single
regulator is sufficient to modify blood flow or arterial tone in response to all stimuli.
Therefore, the vasculature has evolved numerous complementary mechanisms that
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regulate the vasodilatory response to exogenous and endogenous signals. However,
understanding the various modifiers of arterial tone (e.g., KV channels) requires a deeper
understanding. We will describe the link between the role of KV channels and their
associated auxiliary subunits as crucial regulators of arterial tone in further detail in this
review and with the entirety of this work.

c. Part 2: Biochemical and physiological properties of K+ channel associated AKR6A
(KVβ) proteins
Voltage-gated potassium (KV) channels play an essential role in the regulation of
membrane excitability and thereby control physiological processes such as cardiac
excitability, neural communication, muscle contraction, and hormone secretion. Members
of the Kv1 and Kv4 families associate with auxiliary intracellular Kvβ subunits, which
belong to the aldo-keto reductase superfamily. Electrophysiological studies have shown
that these proteins regulate the gating properties of Kv channels. Although the three gene
products encoding Kvβ proteins are functional enzymes in that they catalyze the
nicotinamide adenine dinucleotide phosphate (NAD[P]H)-dependent reduction of a wide
range of aldehyde and ketone substrates, the physiological role for these proteins and
how each subtype may perform unique roles in coupling membrane excitability with
cellular metabolic processes remains unclear. Here, we discuss current knowledge of the
enzymatic properties of Kvβ proteins from biochemical studies with their described and
purported physiological and pathophysiological influences.
The aldo-keto reductases (AKRs) comprise a group of oxidoreductase enzymes
that catalyze the reduction of endogenous and xenobiotic carbonyl compounds. These
enzymes are ubiquitous among eukaryotic and prokaryotic organisms and share
significant structural identity in that they all possess a C-terminal active site region within
11

a triose-phosphate isomerase (TIM) barrel (α8/β8) motif with three loops at the base of the
barrel that govern substrate binding.94,95 The utility of this structural arrangement among
the AKRs allows for flexibility in binding and metabolizing a wide range of chemical
substrates that includes aliphatic and aromatic aldehydes and ketones, monosaccharides,
steroids, and polycyclic aromatic hydrocarbons.96-98 All AKRs require nicotinamide
adenine dinucleotides (i.e., NAD(P)H) as a cofactor for hydride transfer

99

and their

function can thus be modulated by the cellular redox state of electron carriers used in
many intermediary metabolic reactions.
Most human AKRs are soluble monomeric proteins that are found in the cytosolic
compartment. An exception to this are members of the AKR6 subfamily, which form
tetrameric complexes that are associated with the pore-domains of voltage-gated
potassium (Kv) channels (i.e., the Kvβ proteins).100,101 The Kv channels are a large family
of transmembrane K+-permeable ion channels that, via regulation of membrane potential
in excitable cell types, control numerous physiological processes, including neuronal
excitability, hormonal secretion, and muscle contraction.35,102,103 While this assembly
between a catalytically active AKR and ion channel has stimulated several intriguing
hypotheses regarding its evolutionary conservation and potential physiological role(s) 104,
there is limited information about the potential in vivo role for the Kvβ proteins in the
cardiovascular, endocrine, and nervous systems, and it is unclear how these proteins may
regulate diverse cellular physiological processes and pathophysiological development.
While the enzymatic properties and cellular functions of the AKR family have been
reviewed (readers are referred to

), we will discuss the enzymatic properties of the

95,105

Kvβ proteins, including how these properties may relay metabolic information to the Kv
channel gating apparatus. Additionally, these subunits may serve as molecular
transducers that couple metabolism and membrane electrical signaling in excitable cell
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types. While underscoring key remaining questions that require further investigation, we
discuss the potential efficacy of small molecules or peptides that selectively modulate Kvβ
expression or functionality as a novel class of therapeutics that could prevent or reverse
pathological changes, and therefore may be useful interventions for controlling excitability
under a variety of different physiological and pathological conditions.

Molecular and structural biology
In the human genome, there are ~35 genes encoding Kv channel pore proteins
belonging to 12 subfamilies (i.e., Kv1.x – Kv12.x).106 The basic Kv channel tertiary
structure consists of a multi-subunit complex of pore-forming proteins with a diverse
repertoire of associated auxiliary and regulatory proteins. The pore domain is formed by
the tetrameric assembly of four distinct transmembrane subunits (α) that are arranged
around a central axis to form a membrane-traversing ion conduction pore that is highly
selective (~10,000 fold more selective for K+ than for Na+) and efficient for K+ transport
(~107 K+ ions channel-1 sec-1).107-109 Kvα subunits are 70-100 kDa in mass and consist of
six membrane-spanning α helices (S1-S6) with S1-S4 forming the voltage-sensor domain
and the S5-S6 segments of each contributing to the pore lining with selectivity filter. A
highly conserved series of positively charged arginine residues within the S4 region form
the voltage sensor of the channel that responds to changes in membrane voltage to
constrict or dilate the central pore.110 In native channel complexes, members of a particular
Kv family (e.g., Kv1) are known to interact with other functional members of the same
family, giving rise to heteromeric alpha pore complexes with variable gating properties,
which could ultimately increase diversity among functional channels.111,112 This is thought
to occur through highly conserved regions within the intracellular T1 domain, which also
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serves as a docking site for intracellular subunits. Association with conserved regions
among accessory Kv proteins also allows for the formation of heterotetrameric auxiliary
subunit complexes, which, as described below, may further add to the functional diversity
of native channels.
Although the expression and assembly of four Kvα subunits is the minimum
requirement to form a functional channel, association of the pore-domain with a diverse
set of accessory subunits, such as Kvβ, KChAP, KChIP, and MinK, imparts multimodal
regulatory features to Kv channels in vivo.113 Members of the Shaker (Kv1) and Shal (Kv4)
families are known to associate with Kvβ subunits.114,115 The human genome contains
three genes that encode Kvβ proteins (KCNAB1, KCNAB2, KCNAB3) and their transcripts
are alternatively spliced to generate additional variants. Early studies suggesting the
functional importance of Kvβ proteins discovered that a leg shaking phenotype in
Drosophila melanogaster (i.e., ‘hyperkinetic’) was the result of a mutation in a homologue
of the mammalian Kvβ peptides. Subsequent sequence analyses led to the unexpected
finding that the Kvβ subunits shared significant homology (15-30% amino acid identity)
with members of the AKR superfamily.104,116 Upon crystallization of Kv1.2-Kvβ2, it was
found that Kvβ proteins possess a conserved C-terminal β-barrel structural fold with tightly
bound nicotinamide cofactor and, consistent with findings from sequence alignments, the
active site had all characteristic features of a catalytically active AKR, including a wellconserved cofactor binding site and a distinct substrate binding pocket.100,117 Indeed, in
these earlier reports on the X-ray crystal structure of a Kv channel complex, and more
recently in a study demonstrating the single-particle cryo-electron microscopic structure
of Kv1.2-Kvβ2 expressed in lipid nanodiscs

, electron density could be resolved from
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NADP+ that was bound to the β subunits.
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The active site structure of the AKR6 family is unique in that the α8/β8 motif has an
additional helix attached to a long loop between β9 and α7 near the cofactor binding
pocket.95 The functional significance of this modification that is shared among AKR6
members is not presently clear. At the quaternary level, the β1 and β2, which are
perpendicular to the central axis of the barrel, along with the α2-β5-α3 region, form the
intersubunit interface region that participates in β tetramerization, while the α5-α6 region
interacts with the T1 docking domains of the Kvα proteins.100,101 Thus, via the T1 domain,
the active site of Kvβ can influence the conformation of the voltage sensing apparatus and
thereby impact gating properties because of catalytic activity and/or pyridine nucleotide
cofactor binding.

Enzymology and channel biophysics
A prerequisite for investigating and understanding the potential physiological or
pathological roles of the Kvβ proteins is a thorough understanding of their catalytic
properties and the identification of potentially relevant endogenous or xenobiotic carbonyl
substrates. The Kvβ proteins bind pyridine nucleotides, with binding affinities in the low
micromolar range (i.e., 0.1-4 μM). The proteins display a ~10-fold greater affinity for
NADP(H) compared to NAD(H) cofactors.119 Considering that in most metabolically active
cells, the NADPH:NADP+ ratio is substantially higher than that of NADH:NAD+, while the
absolute concentration of NADP(H) is much lower than that of NAD(H) 120,121, the cofactor
predominantly used by Kvβ proteins in vivo is not clear and likely varies with respect to
cell type. Kvβ2 catalyzes the reduction of a wide range of aldehydes and ketones, although
preferential binding and reduction of aldehydes versus ketones, and higher catalytic
efficiency for aromatic aldehydes was reported for this subunit.122 For example, Kvβ2
shows higher catalytic activity with aromatic carbonyls such as phenanthrenequinone than
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with straight chain aldehydes such as acrolein or 4-oxo-nonenal.122 Little or no activity was
observed with steroids such as cortisone. Significantly, the protein was also found to be
active with products of lipid peroxidation, such as 1-palmitoyl, 2-oxovaleroyl, phosphatidyl
choline (POVPC). Given that POVPC and related aldehydes are generated during the
oxidation of unsaturated fatty acids in the plasma membrane and that Kvβ is tethered
within close proximity to the membrane, it appears plausible that the catalytic function of
Kvβ may be to detoxify lipid peroxidation products and thereby protect Kv channels from
oxidative damage. Alternatively, binding to lipid peroxidation products could be a potential
regulatory mechanism that could alter Kv kinetics under conditions of oxidative stress
(e.g., to trigger apoptosis). Although future studies are required to distinguish between
these possibilities and to identify other endogenous substrates, the catalytic reactivity of
the protein with aldehydes could represent an important link that would regulate Kv
channel activity as a function of Kvβ catalysis (regulation of electrical activity by
metabolism) or Kvβ catalysis by Kv activity (regulation of metabolism by electrical activity).
In either scenario, the link between metabolism and excitability could represent a
regulatory mode with profound implications for neural, cardiac, and muscle excitability.
The catalytic activity of Kvβ2 has been found to be sensitive to both pH and ionic
strength. Measurements of the enzyme activity at various pH and ionic concentrations
found that enzyme activity is maximal between pH 7.2-7.4 and relatively insensitive to
varied phosphate concentrations between 100 mM and 250 mM. Yet, at low phosphate
concentrations (≤ 50 mM), enzymatic activity is significantly decreased

122-124

and is not

impacted by the addition of NADH and or NAD+, suggesting that the enzyme functions
most effectively at a specific ionic strength. As with other AKRs such as aldose reductase
and aldehyde reductase, the mechanism of Kvβ catalysis is consistent with an ordered bibi rapid equilibrium reaction in which the nucleotide cofactor is the first to bind and the last
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to dissociate. Consistent with this, the binding affinities for NADPH and NADP+ by Kvβ2
are significantly different, as NAD(P)H binds with 4-times greater affinity than NADP+. The
sequence of cofactor and substrate binding was confirmed using variable concentrations
of 4-NB and NADPH to establish the initial velocity, the starting rate of enzymatic activity.
When plotting initial velocity against the different NADPH concentrations, a rapid
equilibrium mechanism was predominant, indicative of NADPH binding prior to
substrate.122
The cofactor binding kinetics for Kvβ2, determined by monitoring the reduction in
fluorescence of the Kvβ2 reporter fluorescence by addition of each respective cofactor,
provided insight into the phasic behavior and rate limitation of catalysis.123 By measuring
the dependence of observed kfast and kslow of kinetic traces on NADP(H) concentration, it
was suggested that the binding of NAD(P)H to Kvβ could be described as a three-step
process consisting of rapid formation of a loose enzyme-cofactor association, a slow
conformational change that securely seats the cofactor in the active site of the enzyme,
and further stabilization of the NADPH cofactor to its binding site.122,123 The binding of
NADP+, however, follows the two step model of binding affinity, suggesting that the second
conformational change observed with NADPH binding that prevents nucleotide exchange
is absent in the binding of oxidized nucleotide.123 Moreover, studies performed using
mutant Kvβ2 in which the catalytic site tyrosine (Y90) is replaced with phenylalanine
(Kvβ2Y90F) suggest that high affinity nucleotide binding is not significantly impacted by loss
of catalytic function.122
By binding of cofactors to the Kvβ subunits, Kv channel activation and inactivation
are sensitive to changes in intracellular pyridine nucleotide redox state, which is reflected
in the ratio of intracellular NAD(P)H/NAD(P)+.124 Modulation of Kv activity by oxidized and
reduced pyridine nucleotides is determined by the identity of Kvβ subunits present.125,126
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Unlike Kvβ1 and Kvβ3, the Kvβ2 subunit lacks an inactivating N-terminus tail-like
structure.127,128 Despite this structural difference, Kvβ2 has a common binding affinity to
the α subunit T1 domain.100 Consistent with this, the C-terminal domain of the Kvα subunits
is critical for proper association between the Kvα and β subunits.126,129 The underlying
region of importance in the Kv1α C-terminal domain lies between Arg-543 and Val-583 of
Kv1.5, a region with differential affinities for NAD(P)H-bound versus NAD(P)+-bound Kvβ.
Thus, nucleotide-dependent modification in subunit binding affinity and associated
conformational changes within the Kvα transmembrane region may represent a potential
mechanism whereby Kvβ redox sensing could alter channel biophysical properties.
The mechanism and biochemical role of cofactor binding in Kvβ-mediated catalysis
are like that observed with other AKRs, such as aldose reductase. As with other AKRs,
NAD(P)H binding promotes a change in protein conformation that stabilizes the cofactor
within the catalytic pocket.123 The affinity of this interaction produces a large change in
free energy that drives catalysis. As little energy is derived from substrate binding to
achieve the transition state, the protein can bind a range of carbonyl substrates. This mode
of high affinity binding to pyridine coenzyme seems well-suited for ion channel regulatory
functions of Kvβ, as it reduces the constraints of aldehyde binding and renders the cofactor
binding pocket an effective sensor of intracellular pyridine nucleotides. Thus, physiological
changes in intracellular NAD(P)H:NAD(P)+ could readily impact Kv gating and membrane
potential regulation. Under conditions of high intracellular NAD(P)H:NAD(P)+ ratio, binding
of reduced cofactor generally enhances the degree and rate of channel inactivation.124,126
However, this effect can be effectively ‘turned off’ upon completion of a catalytic cycle
resulting in substrate reduction and cofactor oxidation. Accordingly, the net effect of AKR
enzymatic function on Kv channel activity likely reflects dynamic homeostatic balance
between pyridine nucleotide redox potential as well as the concentrations and molecular
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identities of local aldehyde and ketone substrates, which collectively reflect cellular and
subcellular metabolic activity.

Physiological roles
Regulation of membrane excitability by cellular metabolism: Considering that Kv channel
gating

is

modulated

intracellular
nucleotides

by

Schematic 1

pyridine
via

the

Kvβ

complex as stated above,
these proteins have been
proposed as a link between
cellular

function

and

metabolic activity. However,
a clear view of how the Kvβ
proteins operate and modify
channel gating behavior in
their native cellular and tissue
environments has not yet
emerged. Complicating this
issue, native Kv channels

Schematic 1: Balanced redox regulation of whole cell IKv by differential incorporation of
Kvβ proteins in heteromultimeric channels. (A) Schematic of Kvβ1, Kvβ2, and Kvβ3 amino acids
showing conserved COOH terminal region (blue) and variable N-termini (green/red). Several splice variants
which differ in the N-terminal domain have been found for Kvβ1 (1.1-1.3 and Kvβ2 (2.1, 2.2). Ball-and-chain
inactivation domain is shown in red. Adapted from 68. (B) Differential regulation of Kv channel inactivation
by Kvβ1/3 (red) and Kvβ2 (green) in the presence of oxidized and reduced pyridine nucleotides. Adapted
from 101. Kv channels expressed in membranes of excitable cells represent heterogeneous populations of
structures with varying β subunit compositions. Channels that assemble with Kvβ1/Kvβ3 proteins
demonstrate enhanced inactivation upon binding to reduced pyridine nucleotides. Conversely, sensitivity
of channel inactivation to pyridine nucleotide redox is absent in channels that associate with Kvβ2, which
does not contain the ball-and-chain. (C) Graph showing proposed regulation of Kv channel activation,
inactivation, and single channel and whole-cell IKv as the ratio of expressed Kvβ2:Kvβ1 or Kvβ3 is increased.
A reduction in channel inactivation with increased Kvβ2:Kvβ1/3 in native Kv channels could produce an
increase in single channel Kv activity and elevation in steady-state IK, which may lead to significant
alteration in membrane excitability and responsiveness to changes in cellular metabolism. Solid lines
represent predicted observed effects on whole cell Kv activation, inactivation, and IK. Dashed lines show
plausible graded effects of Kvβ2:Kvβ1/3 ratio on inactivation and IK.

likely consist of heteromeric assemblies of multiple gene products and splice variants,
which have not yet been functionally characterized. Moreover, the expression levels of
Kvα and β proteins and how their stoichiometry within a given population of functional
channels is determined may be cell specific. It is also conceivable that the molecular
identity of predominant subunits utilized by a cell may be modified because of changing
metabolic cues. Considering the functional diversity imparted by variable N-termini of the
19

Kvβ subtypes, the ratio of Kvβ2:Kvβ1/3 present in the Kv auxiliary complex could have a
significant impact on inactivation (Schematic 1). For example, in channels with noninactivating Kvα pore subunits (e.g., Kv1.5) and predominantly Kvβ2 subunits, channel
inactivation may be slower, as C-type inactivation would be the primary mode of
inactivation.127 Conversely, in channels consisting of variants of Kvβ1 or 3, channel
inactivation likely occurs within a faster time frame, as these subunits would contribute to
rapid N-type inactivation. In addition to interaction and regulation of Kvα function by the
Kvβ proteins, interaction between multiple types of Kvβ can influence the net function of
the Kvβ complex on channel gating. For example, incorporation of Kvβ2 can lead to
significant inhibition of N-type inactivation imposed by Kvβ1 subunits within the same
channel complex.130 Nonetheless, the extent to which these subunits impact channel
activation and inactivation would also be dependent upon pyridine nucleotide redox ratios
in the submembrane compartment, as discussed above. Thus, it is plausible that the cell
could dynamically fine-tune the regulatory properties of membrane potential to changing
metabolic conditions by altering the ratio of Kvβ subunits within the population of functional
membrane-inserted channels. In the remainder of this section, I will provide a brief
overview of the importance of Kv channels to the cardiovascular, nervous, endocrine, and
immune systems, and how the functional expression of Kvβ may influence physiological
processes of excitable cells types within each.

Cardiovascular system: In the mammalian heart, multiple types of Kv channels mediate
outward K+ currents with variable activation and inactivation properties that collectively
shape the cardiac action potential.131,132 Attesting to the importance of Kv channel function
to cardiac physiology is the robust association between cardiac arrhythmias with
mutations in Kv channel subunit genes

, as well as defective ventricular action

133,134
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potential repolarization in mice lacking Kv proteins.135-137 The murine heart is known to
express Kvβ1.1, Kvβ1.2, and Kvβ2 proteins.138 Kvβ1 associates primarily with proteins of
the Kv4 family and loss of Kvβ1 reduces the abundance of Kv4.3 in the sarcolemma,
blunts transient outward K+ current, and prevents modulation of action potential duration
by changes in pyridine nucleotide redox state.138,139 The physiological role of Kvβ2 remains
unclear. Considering that the heart expresses multiple Kvβ subtypes, it is plausible that
the promiscuous association between both Kvβ1 and Kvβ2 proteins with Kv1 and Kv4
channels contributes to priming cardiac Kv channels for modulation of channel
inactivation. Under conditions of altered nucleotide redox (e.g., altered cardiac workload
stress, ischemia), this influences the duration of the early and intermediate phases of
repolarization of the action potential.
The Kv channels expressed by vascular smooth muscle are a predominant
regulator of vascular tone, and therefore control blood flow and organ perfusion.140 Kv1
expression and function has been reported in a number of vascular beds, including
coronary, pulmonary, mesenteric, and cerebral arteries, among others.141 Inhibition of Kv1
channels induces vasoconstriction, suggesting that Kv1 channels are tonically active in
vascular smooth muscle to oppose vascular tone development.142 However, little is known
regarding the expression and function of Kvβ subunits in the vasculature. Our laboratory
recently reported that murine coronary arterial myocytes express heteromeric assemblies
of Kvβ complexes in association with Kv1.5 alpha subunits, and that genetic deletion of
Kvβ2 reduces the membrane expression of Kv1.5

, similar to that reported in neurons

143

and heterologous expression systems.144,145 Although we and others have speculated that
these subunits may play an important regulatory role in coupling tissue oxygen demand
with vasodilatory function in various vascular beds
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, further research is needed to

12,146,147

increase our understanding of how the Kvβ proteins operate in the vasculature and how
these may participate in functional or metabolic hyperemic responses.
Unlike most peripheral arteries and arterioles, hypoxia causes rapid and profound
vasoconstriction of pulmonary arteries.148 This phenomenon, referred to as “hypoxic
pulmonary vasoconstriction” (HPV), is thought to be an important physiological response
of the pulmonary circulation that shunts blood away from under-ventilated lung tissue.149
However, excessive HPV can lead to pulmonary hypertension, right ventricular
hypertrophy, and heart failure.150 Kv1 channels regulate pulmonary vascular smooth
muscle membrane potential and mediate the HPV response.151,152 HPV is significantly
impaired after genetic deletion of redox sensitive Kv1.5 channels, and in vivo gene transfer
of Kv1.5 normalizes HPV in a model of chronic pulmonary hypertension.153,154 The
association of the Kv1 channels of the pulmonary vasculature with Kvβ proteins may be
integral to the HPV response. In support of this, bovine pulmonary arteries exhibit a
significant increase in Kvβ1.1 expression with further progression towards higher order
pulmonary arteries and arterioles.155 Higher expression of Kvβ1.1 may impart enhanced
inactivation to Kv channels in small vessels in which HPV is apparent by allowing sensing
of increases in NADH:NAD ratio upon a decrease in mitochondrial oxidative metabolism
during periods of hypoxia.156 Nonetheless, the precise role of the Kvβ1 subunits in the
HPV response has not been directly tested.

Nervous system: Multiple types of Kv channels expressed in the central nervous system
control membrane potential and excitability of neurons, and coordinate diverse processes
such as action potential propagation and back propagation, neurotransmitter release, and
apoptosis.157 The altered activity or expression of Kv channel proteins in the nervous
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system has been associated with human pathological conditions such as epilepsy,
multiple sclerosis, and Alzheimer’s disease.158-161 Neurons express multiple Kv alpha
subunits that form functional channels, confer A-type K+ currents, and likely associate with
Kvβ proteins, including dendritic Kv4.1, Kv4.2 and Kv4.3 subunits

162-164

and presynaptic

Kv1.4 subunits.162 Variants of all three Kvβ gene products have been found in the brain,
with Kvβ2 being the predominant form 165-171, suggesting that Kv1 and Kv4 channels may
assemble into heteromers with considerable functional diversity that may participate in the
determination of neuronal phenotype. In addition to modulation of channel activation and
inactivation characteristics, Kvβ proteins may play a chaperone role and regulate the
subcellular targeting of specific populations of Kv channels to distinct neuronal regions
(i.e., axonal versus dendritic targeting).144,145 Genetic deletion of Kvβ2 in mice increases
mortality, reduces body weight and results in defects in thermoregulatory processes

,
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whereas mice lacking Kvβ1.1 have reduced Kv current inactivation, frequency-dependent
spike broadening, and slower afterhyperpolarization compared with wild type mice. These
changes in neuronal electrical signaling are associated with impaired learning and
memory in water maze and social transmission tasks.173 Although definitive evidence is
lacking, it is possible that changes in brain electrical activity could be strongly modulated
by Kvβ-dependent regulation of Kv1 and Kv4 activity during periods of altered neuronal
cytosolic redox potential, for example, changes in glucose metabolism.

Endocrine and immune systems: Multiple Kv channel subtypes also participate in the
physiological regulation of membrane potential in several cell types outside of the
cardiovascular and nervous systems. Studies have suggested that these channels, via
regulation of Ca2+ influx, also control hormonal secretion in cells of the endocrine system.
For example, in pancreatic beta cells, an increase in Ca2+ influx following increased
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cellular ATP:ADP ratio and inhibition of ATP-sensitive K+ channels (KATP) stimulates the
release of insulin.161,174 Repolarization of the cell back to resting potential and cessation
of the secretory process, is mediated, in part, by Kv-mediated outward K+ currents, which
are likely mediated by a variety of Kv channel subtypes, including Kv1, Kv2, Kv4.175
Although the expression profile of associated Kvβ proteins in pancreatic islets is not
known, modulation of Kv activity by these subunits may be essential to proper electrical
signaling following a glucose-induced rise in NADPH:NADP+ ratio in beta cells.176 In
addition, Kv1 channels have also been shown to be expressed by cells of the immune
system.57 Kv1.5 and Kv1.3 are the predominant Kvα proteins in macrophages and
inhibition of Kv1 channels can prevent macrophage activation and proliferation.177-179 Bone
marrow-derived macrophages express all known variants of Kvβ1, and Kvβ2.1 proteins
; LPS- and TNF-α induced activation differentially impact the abundance of these
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proteins and modify channel inactivation. This suggests that modification of Kv1 channel
pore and auxiliary subunit composition may reflect an adaptive mechanism that could alter
the functional properties of cells in the immune system.

Therapeutic implications
Based on current knowledge of the physiological roles of Kvβ proteins, it is
plausible that these proteins and their functional properties may represent an
advantageous therapeutic target over conventional pharmacological ion channel blockers
for several conditions. Classical inhibitors of AKRs show little inhibition of Kvβ-mediated
catalysis, and currently, only a few pharmacological agents are known to impact Kvβ
function; these act primarily as inhibitors of catalytic activity or by disrupting the
association between the Kvβ and Kvα T1 docking domain. A recent study identified the
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acidic dopamine metabolite 3,4-dihydroxphenylacetic acid (DOPAC) as an effective
inhibitor of Kvβ2-mediated reduction of 4-nitrobenzaldehyde, inhibiting the production of
4-nitrobenzyl alcohol by ~40%

, albeit at supraphysiological concentrations. Additional
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nonendogenous inhibitors such as the cardioprotective drug resveratrol and plant derived
flavonoid rutin, only slightly inhibit Kvβ2 catalytic activity by ~38% each. Alternatively,
corticosteroids, such as cortisone, directly interact with Kvβ to increase Kv1 channel
activity through binding near the cofactor binding pocket and the inter-subunit interface,
resulting in dissociation of the Kvβ from the channel.182 There are currently no known
pharmacological agonists that can selectively enhance Kvβ catalytic function. Further
elucidation of compounds that can selectively modulate the function of the proteins may
be valuable as novel therapeutics for the treatment of multiple disorders. Although the
possibility for using compounds identified by these initial studies as Kvβ modulators as
therapeutics is unlikely, they provide a useful foundation for further research into more
beneficial chemical analogues that may possess more specific biological actions resulting
from altering Kvβ function while avoiding off target effects.
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HYPOTHESIS

The regulation of vasomotor control has been studied for over 100 years, however
this system in an altered metabolic state has not been well established. Debate over what
regulates vasomotor control to constrict or dilate vessels has continued since the first
observations of endothelial and sarcolemmal mediated vasomotion.67 Over the last
several decades mediators of vasomotor control during altered metabolism have been
proposed and disproved or relegated as weak regulators. However, based on the literature
and previous studies conducted by our laboratory and others, I have developed my
present hypothesis to begin to investigate this mystery, it states: KVβ subunits functionally
regulate resistance artery diameter. To address this hypothesis, we developed three key
questions or sub-hypothesis; 1) Does deletion of either KVβ subunit alter vasoconstriction;
2) Does deletion of either KVβ subunit affect vasodilation to stimuli that reflect an altered
metabolic state; and finally, 3) Does catalytic activity (of the KVβ2 subunit) impact
vasodilatory function?
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INTRODUCTION

The imbalance between myocardial oxygen supply and demand is a salient
pathophysiological feature of heart disease, which remains the leading cause of death
worldwide.183 Insufficient myocardial perfusion is associated with cardiac dysfunction in
patients with heart failure, hypertension, diabetes, and coronary artery disease.184-187 A
discrepancy between oxygen supply and demand is commonly observed in patients with
suppressed coronary vasodilator reserve—even in the absence of stenoses in large
coronary arteries—likely due to the inability of small arteries and arterioles to respond to
metabolic demand.188,189 Despite the vital importance of oxygen delivery to the
preservation of cardiac function, the fundamental mechanisms by which the coronary
vasculature responds to

Schematic 2

fluctuations in metabolic
demand
myocardium

of

the
remain

poorly understood.
In a healthy heart, the
Schematic 2: Proposed mechanism for KVβ mediated modification of KV channels in the
presence of altered pyridine nucleotide redox ratio. The proposed differential response of KVβsubunits to an altered pyridine nucleotide redox ratio. For example, in the presence of increased NADH the
tail of the KVβ1 complex inhibits the efflux of K+ via KV1.x channels; however, KVβ2 increases the efflux of
K+ in the presence of increased NADH, inducing membrane hyperpolarization and inhibiting the inward flow
of Ca+2 thus mediating vasodilation. By contrast, an increase in NAD+ would result in opposition of the
example.

coronary arteries and
arterioles operate in a
partially

constricted

state of tone, such that dilation or constriction occurs depending on the need for oxygen
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and nutrient delivery.8,190 As myocardial oxygen consumption increases (e.g., increased
heart rate, myocardial contractility, or afterload), the heart requires instantaneous
increases in oxygen supply to sustain oxidative energy production by the cardiomyocytes.
With little reserve for increased oxygen extraction, sustained cardiac function relies on the
intimate link between local and regional metabolic activity and vasodilation of the coronary
vascular bed to deliver adequate blood flow to the active myocardium (i.e., metabolic
hyperemia).191 In searching for the molecular entities coupling vascular function with
myocardial metabolism, recent studies from our group56,192 and others193 have indicated
that acute increases in cardiac work promote coronary vasodilation and hyperemia via
activation of smooth muscle voltage-gated K+ channels belonging to the Kv1 family.
Nonetheless, how vascular Kv1 channels sense changes in myocardial oxygen demand
to regulate blood flow to the heart is unknown. Furthermore, the molecular contributions
of the Kv1 channel subunits complex composition and whether these functionally
contribute to metabolic hyperemia in the heart has not yet been determined. Based on the
literature, and our own data presented here, we posit a physiological role for the KV1
channels and their β-subunits as mediators of the arterial hyperemic response.
In this study, we tested the hypothesis that vascular function is regulated by the
intracellular auxiliary Kvβ proteins. As discussed in c. part 2, the Kvβ proteins are
members of the aldo-keto reductase (AKR) superfamily and differentially regulate Kv1
function upon changes in cellular redox status, thus representing a plausible link between
metabolic activity and membrane excitability that can influence vasoreactivity. The
mammalian genome contains three genes encoding Kvβ proteins, which are expressed in
coronary arterial myocytes of humans194 and rodents.143 Our previous work indicated the
presence of Kvβ heteromers of Kvβ1.1 and Kvβ2 in native Kv1.5 channels of coronary
arterial myocytes.143 Using a combination of genetically engineered animals with ex vivo
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and in vivo approaches, we report that vasoreactivity is controlled by the contrasting
regulatory functions of Kvβ1.1 and Kvβ2 proteins.
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MATERIALS AND METHODS
Animals
All animal procedures were conducted as approved by Institutional Animal Care and Use
Committees at the University of Louisville. Experiments were conducted using agematched mice and littermates when possible. Additionally, Kvβ1.1-/- and Kvβ2-/- mice 114,173
and strain-matched wild type (C57Bl/6N and 129/SvEv, respectively) mice (25-30 g body
mass) were bred in house and fed ad libitum normal rodent chow. Transgenic animals
were generated (Cyagen) with mouse Kcnab1 (NM_01059734) as the control of the
tetracycline responsive element (TRE, 2nd generation) promoter (TRE-Kcnab1.1).
Hemizygous TRE-Kcnab1.1 mice were bred to transgenic mice with the reverse
tetracycline transactivator under the control of the murine SM22-alpha (SM22α or
transgelin) promotor (SM22α-rtTA; Jackson Laboratories, stock no. 006875, FVB/N-Tg
(Tagln-rtTA)E1Jwst/J)195 to yield double hemizygous SM22α-rtTA:TRE-Kcnab1.1 and
littermate single transgenic SM22α-rtTA controls. Male mice (aged 3-6 months) were used
for the study. All animals were housed in a temperature-controlled room on a 12:12
light:dark cycle with ad libitum access to food and water. Mice were euthanized by
intraperitoneal injection of sodium pentobarbital (150 mg∙kg-1) and thoracotomy and
tissues were excised immediately for ex vivo functional measurements and biochemical
assessments.
Chemicals
U46619 (CAS#: 56985-40-1), psora 4 (CAS#: 724709-68-6) was purchased from
Tocris Bioscience (Tocris Bioscience, Bristol, United Kingdom). Chemicals purchased
30

from Sigma-Aldrich (St. Louis, Missouri, US) include: D-glucose (CAS#: 50-99-7),
NaHCO3 (CAS#: 144-55-8), sodium chloride (CAS#: 7647-14-5), calcium chloride (CAS#:
10043-52-4), magnesium chloride (CAS#: 7786-30-3), HEPES (CAS#: 7365-45-9),
potassium chloride (CAS#: 7447-40-7), potassium phosphate monobasic (CAS#: 777877-0), sodium lactate (CAS#: 867-56-1), nifidepine (CAS#: 21829-25-4), and forskolin
(CAS#: 66575-29-9). We used a Sartorius Arium mini water system (Sartorius Lab
Instruments GmbH & Co., Goettingen, Germany).
Arterial diameter measurements
Third and fourth order branches of mesenteric and first and second order left anterior
descending coronary arteries were dissected and kept in ice-cold isolation buffer
consisting of (in mM): 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, 7 D-glucose, pH
7.4. Isolated arteries were used for arterial diameter measurements within 8 h after
dissection. Isolated arteries were cleaned of connective tissue and cannulated on glass
micropipettes mounted in a linear alignment single vessel myograph chamber (Living
Systems Instrumentation, St. Albans, VT, USA). For a set of experiments, the vascular
endothelium was functionally ablated by passage of air through the lumen (~30 s) during
the cannulation procedure. After cannulation, the chamber was placed on an inverted
microscope and arteries were equilibrated at 37°C and intravascular pressure of 20
mmHg, maintained with a pressure servo control unit (Living Systems Instrumentation, St.
Albans, VT, USA) under continuous perfusion (3-5 ml∙min-1) of physiological saline
solution (PSS) consisting of (in mM): 119 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgCl2, 7 Dglucose, 24 NaHCO3, 2 CaCl2, maintained at pH 7.35-7.45 by aerating with 5% CO2, 20%
O2, balance N2.
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Following an equilibration period (45-60 min), lumenal diameter was continuously
monitored and recorded with a charge coupled device (CCD) camera and edge detection
software (IonOptix, Milton, MA, USA). Experiments were performed to examine effects of
step-wise increases in intravascular pressure (20-100 mmHg), elevated [K+]o (via
isosmotic replacement of KCl for NaCl), the synthetic thromboxane A2 analogue U46619
(Tocris Bioscience, Minneapolis, MN, USA), adenosine (Sigma Aldrich, St. Louis, MO,
USA), or L-lactate (Sigma Aldrich, St. Louis, MO, USA). For a set of experiments, hypoxic
bath conditions were generated by perfusion of 1 mM Na2S2O4-containing PSS that was
aerated with 5% CO2 (balance N2). Bath O2 levels were measured using a dissolved
oxygen meter (World Precision Instruments, Sarasota, FL, USA). At the end of each
experiment, the maximum passive diameter was measured in the presence of Ca2+-free
PSS containing the L-type Ca2+ channel inhibitor nifedipine (1 μM) and adenylyl cyclase
activator forskolin (0.5 μM), as described previously.196,197 Vasoconstriction is expressed
as a decrease in arterial diameter relative to the maximum diameter at a given
intravascular pressure. Changes in diameter (e.g., vasodilation) are normalized to
differences from baseline and maximum passive diameters for each experiment.
Statistics
Data are presented as mean ± SEM. Data were analyzed using GraphPad Prism software
using paired or unpaired Student’s t-tests, and Mann Whitney U and Wilcoxon signed rank
non-parametric tests for comparisons of two experimental groups. One-way and two-way
analysis of variance or non-parametric tests with Tukey post-hoc tests were used for
comparisons of multiple groups and repeated measures datasets, as indicated in Figure
Legends. P-value less than 0.05 was considered statistically significant.
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RESULTS

Lactate induced vasodilation in mesenteric and coronary arteries
The vasoreactivity to lactate (a byproduct of increased cellular metabolism that is
converted by the lactate dehydrogenase enzyme to pyruvate and increases the NADH to
NAD+ ratio) was compared between mesenteric and left anterior descending coronary
arteries from WT and KVβ2-/- mice Figure 1 (A, B). As indicated in the representative
traces Figure 1 (A, B), increasing concentrations of lactate (5-20 mM) induced dilation.
This response is summarized in Figure 1 (G, H).

I investigated the role of the KV1

channel in mediating vasodilation in response to vasoactive compounds (e.g., lactate), we
first perfused the vasoactive compound (lactate) at several concentrations (5-20 mM) in
the absence and presence of known general KV1 channel inhibitor Psora-4. As indicated
in Figure 1 (A, B) 15 mM lactate induced vasodilation in both mesenteric and coronary
arteries and addition of Psora-4 (C, D) ablated the vasodilation response. To assess the
potential role of KVβ-subunits in KV1 channel mediated vasodilation in response to lactate,
measurements of intralumenal diameter were obtained from freshly isolated mesenteric
arterioles pressurized at 80 mmHg. Arteries were preconstricted (100 nM U46619) and
perfused increasing concentrations of lactate (5-20 mM). In mesenteric and coronary
arteries isolated from WT mice we observed that when 20 mM lactate was perfused into
the bath arteries dilated and this was significantly reduced with addition of the Kv1-channel
inhibitor Psora-4 (100 nM) (Figure 1A, B and C, D, respectively). However, in arteries
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from KVβ2-/- mice demonstrates lactate (15 and 20 mM) induced vasodilation was
significantly ablated Figure 1 (E, F) compared to their respective wildtype.

34

Figure 1
Coronary

Mesenteric
Wildtype
L-lactate (mM)
250
200
150
100
50

Ca -free
nifed
2+

20

5 10 15

5 min

L-lactate (mM)
150

10

5

100

15

Ca2+-free
nifed

20

50
0

5 min

+ psora-4 (500 nM)

C

D

250
200
150
100
50

L-lactate (mM)
10 15
5

arterial diameter (μm)

arterial diameter (μm)

B

arterial diameter (μm)

arterial diameter (μm)

A

Ca2+-free
nifed
20

5 min

150
100

10

5

50
0

Ca2+-free
nifed

L-lactate (mM)
15

20

5 min

Kvβ2 -/-

F

% change in diameter

G

Ca2+-free
nifed

L-lactate (mM)
10

5

15

arterial diameter (μm)

250
200
150
100
50

20

5 min

60

WT

Kvβ2

H

-/-

% change in diameter

arterial diameter (μm)

E

WT + psora-4

40

*

20

*

0
-20

0

5
10
15
L-lactate (mM)

150
100

10

5

15

20

50
0

5 min
Kvβ2 -/WT
WT + 500 nM psora-4

75
50
25

* *

0
-25
-50

20

Ca2+-free
nifed

L-lactate (mM)

0

5

10
15
L-lactate (mM)

20

Figure 1. KV1 channels mediate lactate induced vasodilation in small resistance arteries.
(A, B, C, D, E, F)
Representative traces of arterial diameter recordings of pressurized (80 mmHg) thromboxane A2 analogue preconstricted
(100 nM U4661) mesenteric and left anterior descending (LAD) coronary arteries from WT (± psora4), and KVβ2-/- mice
before and after perfusion of sodium lactate (5-20 mM). Each experiment was concluded with the addition of Calcium free
PSS (Ca2+-free), 1 µM nifedipine (nifed), and 500 nM forskolin (fsk) (n = 5 and 4 arteries mesenteric and coronary
respectively; N = 5 and 4 mice, mesenteric and coronary, respectively; * = P<0.05). (G, H) Summary of lactate induced
dilation for arteries from WT (± psora4), and KVβ2-/-mice (* = P-value <0.05).
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Myogenic tone development is independent of changes to the KVβ-subunit complex
composition.
Regulation of blood flow is tightly controlled by the ability of small resistance
arteries (~100-300 µm)8 to develop myogenic tone and thus regulate vascular resistance.8
Myogenic tone development is an autoregulatory mechanism meant to maintain a
constant flow of blood through resistance arteries. We stepwise increased intravascular
pressure through the physiological range (i.e., 60-100 mmHg). Representative traces of
arteries from KVβ1-null (KVβ1-/-), KVβ2-null (KVβ2-/-) and their respective wildtypes show
that ablation of either KVβ-subunit did not impair myogenic tone development (Figure 1A).
For example, at 80 mmHg, arteries from KVβ1-/- mice (Figure 2B) and KVβ2-/- and
constricted like their respective wildtypes (Figure 2C). Summary graphs show at each
pressure the passive diameters, relative to 0 mmHg, are not different between KVβ1-/-,
KVβ2-/- and respective matched wild types (Figure 2D). These data support the conclusion
that ablation of either KVβ-subunits does not significantly impact the mechanisms that
mediate the development of myogenic tone. Furthermore, these data also verify that the
method of knocking out of the KVβ-subunits does not impact this mechanism of vascular
tone regulation.

36

Figure 2
K Vβ1.1-/-

wt

80

100

150
100

5 min

% decrease in diameter

B

200

20

60

40

80

100

150
100

5 min

C
30

wt

K Vβ1.1

-/-

20
10
0

20 40 60 80 100
intravascular pressure(mmHg)

arterial diameter (μm)

60

20 40

arterial diameter (μm)

200

K Vβ2-/-

intravascular pressure
(mmHg)

% decrease in diameter

arterial diameter (μm)

intravascular pressure
(mmHg)

intravascular pressure
(mmHg)
200

20

40

60

80

100

150
100

5 min

D
30

wt

K Vβ2

-/-

20
10
0

20 40 60 80 100
intravascular pressure (mmHg)

relative passive diameter

A

2.5
2.0
1.5
1.0

wt

K Vβ1.1-/-

2.5
2.0
1.5
1.0

wt

K Vβ2-/-

0

20 40 60 80 100

intravascularpressure(mmHg)

Figure 2. Myogenic tone development is independent from changes to the KVβ-subunit complex composition.
(A) Representative arterial diameter recordings obtained from arteries isolated from WT (129SvEv), Kvβ1.1-/-, and
Kvβ2-/- mice across a range of intravascular pressures, as indicated. Maximum passive diameters, obtained in Ca2+-free
bath solution containing 100 nM nifedipine, are shown for each (dashed traces). (B, C) Bar graphs showing summarized %
decrease in diameter at each intravascular pressure tested for arteries isolated from WT (n = 4 arteries from 4 mice) and
Kvβ1.1-/- (D, n = 5 arteries from 5 mice) mice (D), and WT (n = 6 arteries from 5 mice) and Kvβ2-/- (n = 6 arteries from 5
mice) (P>0.05 at each pressure, respectively (Mann-Whitney U). (D) Summary of passive diameters relative to diameters
at 0 mmHg across the range of intravascular pressures tested for arteries isolated from Kvβ1.1-/- (n = 5 arteries from 5 mice),
Kvβ2-/- (n = 6 arteries from 5 mice), and corresponding WT controls (n = 4 arteries from 4 mice; n = 6 arteries from 5 mice)
( P-value >0.05 at each pressure, respectively (Mann-Whitney U).
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Vasoconstriction response in resistance arteries is not impacted by loss of KVβ subunits.
Changes in membrane potential regulate the flow of ions across the membrane,
as in the case of Ca2+ increased inward flow modulates greater vasoconstriction.198 The
influx of Ca2+ is tightly regulated by efflux of K+ ions which mediate hyperpolarization of the
cell membrane and prevent opening of voltage gated Ca2+ channels (Schematic 2). To
assess whether ablation of KVβ-subunits, KVβ1-/- or KVβ2-/-, modifies the 60 mM K+ induced
vasoconstriction we utilized freshly isolated small resistance arterioles from KVβ1-/- and
KVβ2-/- mice and their respective wildtypes. Introduction of high potassium (>60 mM
potassium) inhibits outward potassium flow effectively clamping membrane potential to
the Nernst potential depolarizing the membrane, opening voltage gated calcium channels,
and inducing vasoconstriction. In response to 60 mM K+, arteries isolated from KVβ1-/- and
WT constricted, respectively (Figure 3A, B). Similarly, in KVβ2-/- and WT, arteries
constricted, respectively (Figure 3C, D). We also examined whether the thromboxane A2
mediated vasoconstrictive response was affected by ablation of either KVβ1-/- or KVβ2-/-.
Representative traces from arteries perfused with the thromboxane A2 analogue U46619
(100 nM) constricted similarly between KVβ1-/- and KVβ2-/- and their respective strain
matched wildtypes (Figure 3C, D). From these data, we can conclude that ablation of
individual KVβ-subunits (KVβ1-/- and KVβ2-/-) does not significantly impact mechanisms of
vasoconstriction in resistance arteries.
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Figure 3. Vasoconstriction response in resistance arteries is not impacted by loss of either Kvβ subunits. (A, B)
Representative arterial diameter recordings obtained from pressurized (20 mmHg) mesenteric arteries before and after
application of 60 mM external K+ (indicated by arrows; A), and summary of 60 mM K+-induced constriction (% decrease in
diameter, B) in arteries isolated from Kvβ1.1-/- (n = 5 arteries from 5 mice), Kvβ2-/- (n = 5 arteries from 4 mice), and strainmatched WT controls (C57Bl6N for Kvβ1.1-/-, n = 4 arteries from 4 mice; 129SvEv for Kvβ2-/-; n = 6 arteries from 5 mice).
P=0.41 and. 0.43, respectively; Mann-Whitney U test. (C, D) Representative arterial diameter recordings from arteries (80
mmHg) before and after application of 100 nM U46619 (indicated by arrows, C), and summary of U46619-induced
constriction (% decrease in diameter, D), from groups as described in B. WT (C57Bl6N): n = 11 arteries from 10 mice;
Kvβ1.1-/-: n = 11 arteries from 11 mice, WT (129SvEv): n = 10 arteries from 9 mice; Kvβ2-/-: n = 10 arteries from 10 mice. Pvalue >0.05 respectively (Mann-Whitney U).
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Adenosine-induced vasodilation is not affected by knockout of KVβ-subunits
Adenosine is a potent vasodilator, which acts via A2A/2B to activate the GS protein
to stimulate adenylate cyclase and increase intracellular cyclic adenosine monophosphate
(cAMP).199 Therefore, in order to assess adenosine induced dilation in the absence of
specific KVβ-subunits, we perfused increasing concentrations of adenosine onto isolated
arteries from KVβ-subunit null (KVβ1-/- or KVβ2-/-) and wildtype mice. Our data show that at
10-5M, adenosine-induced vasodilation is not significantly different between KVβ1-/- or WT
(Figure 4A, B). Similarly, adenosine induced similar vasodilation in isolated arteries from
KVβ2-/- and respective WT mice (Figure 4A, B).
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Figure 4. Adenosine-induced vasodilation is not affected by knockout of KVβ-subunits. Adenosine induced similar
vasodilation in KVβ-null and respective wildtypes. At 10 µM adenosine induced vasodilation is not significantly different
between KVβ1-/- or wildtype (n = 6, 5; N = 6, 4). Similarly, adenosine induced similar vasodilation in KVβ2-/- and wildtype (n
= 4, 4; N = 3, 3). P-values > 0.05 (Mann-Whitney U test).
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Lactate-induces vasodilation independent of endothelial function
The endothelium is considered a key mediator of vasodilation. Lactate could elicit
vasodilation via production of endothelium-derived relaxation factors (e.g., H2O2).
However, we investigated whether the endothelium mediates vasodilation in response to
lactate by comparing endothelial intact and denuded vessels. To confirm inactivation (i.e.,
denudation) of the endothelium we used the SKCa/IKCa opener NS309, which induces
endothelial dependent vasodilation. Figure 5 (A) shows representative traces of intact
and endothelium-denuded (-endo) mesenteric arteries in the presence of the SKCa/IKCa
opener NS309 (1 µM) to confirm loss of function in denuded vessels. The summary data
of these experiments (Figure 5B) display loss of NS309 induced dilation. Figure 5 (C)
shows representative traces of intact and denuded vessels that both dilated to
approximately 20% in the presence of 10 mM lactate. These summary data (Figure 5D)
reveal that lactate induced similar levels of vasodilation in both intact and denuded arteries
indicating that the mechanism of lactate-induced vasodilation is independent of
endothelial function.
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Figure 5

Figure 5: Lactate induced vasodilation independent of endothelial function. (A) Arterial diameter recordings from
preconstricted (100 nM U46619) intact and endothelium-denuded (- endo) in the absence and presence of the SKCa/IKCa
opener NS309 (1 µM). (B) Summary graph showing 1 uM NS309 induced dilation (%) ± SEM in WT arteries with either an
intact or denuded endothelium. n= 5 and 7 arteries from 5 and 4 mice. P = 0.056 (Mann-Whitney U test). (C) Representative
recordings of arterial diameter from preconstricted (100 nM U46619) WT intact and - endo arteries in the presence of 10
mM lactate. (D) Summary bar graph of lactate induced dilation (%) ± SEM in WT intact and - endo arteries. n = 5 and 6
arteries from 5 and 3 mice. P-values > 0.99 (Mann-Whitney U test).
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Overexpression of KVβ1.1 impairs lactate induced vasodilation
Ablation of KVβ1.1 did not impact lactate induced vasodilation as compared to the
respective wildtype Figure 6 A. However, vasodilation was significantly blunted in isolated
arteries in response to extracellular L-lactate when compared with arteries from single
transgenic control mice (Fig. 6 C, D). The overexpression of Kvβ1 emulates the observed
response to lactate in arteries from Kvβ2-/- mice (Fig. 1 E, F). These data indicate a
dynamic difference in the role of the Kvβ-subunits in responding to stimuli (e.g., lactate)
where Kvβ1 opposes, and Kvβ2 enhances, vasodilation.
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Figure 6. Increasing the ratio of Kvβ1.1:Kvβ2 subunits in smooth muscle , not knockout of Kvβ1.1 (Kvβ1.1-/-), inhibit
L-lactate-induced vasodilation. (A, B) Summarized data of Kvβ1.1-/- and SM22α-rtTA:TRE-β1 arteries perfused with
increasing concentrations of L-lactate (5-20 mM) as compared to the respective wildtypes. (C, D) Representative arterial
diameter recordings from 100 nM U46619-preconstricted mesenteric arteries isolated from SM22α-rtTA and SM22αrtTA:TRE-β1 mice in the absence and presence of L-lactate (5-20 mM), as in Figure 5 B. Passive dilation in the presence
of Ca2+-free solution + nifedipine (1 μM) and forskolin (fsk; 0.5 μM) is shown for each recording. Kvβ1-/-: n = 7 arteries from
7 mice; SM22α-rtTA: n = 6 arteries from 5 mice; SM22α-rtTA:TRE-β1: n = 10 arteries from 6 mice; * = P-value <0.05 (twoway ANOVA).
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Association and expression of KV1.2, KV1.5, KVβ1 and KVβ2 are similar in vascular smooth
muscle cells isolated from coronary and mesenteric arteries
The distribution of ion channels, and other proteins expressed in the vasculature
are not consistently distributed across vascular beds. It is essential to show the expression
and colocalization of the KV complex composition is consistent across resistance
vasculature beds. In Figure 7 (A) Both, coronary and mesenteric vascular smooth muscle
cells have similar colocalization of the vascular KV channel complexes (i.e., KV1.2, KV1.5,
KVβ1 and KVβ2). These data are summarized in Figure 7 (B), indicating no significant
difference between coronary and mesenteric myocytes colocalization of KV1.2, KV1.5,
KVβ1 and KVβ2.
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Figure 7. Coronary and mesenteric arterial myocytes colocalization of KV1.2, KV1.5, KVβ1 and KVβ2. (A) Proximity
ligation (PLA) experiments show similar localization of KV1.2, KV1.5, KVβ1 and KVβ2 (red foci) in isolated myocytes
(membrane surface outlined with dots) from both coronary (left) and mesenteric (right) arteries (nucleus visualized in blue
using DAPI) (all scale bars represent 5 µm reference). (B) Summarized data of PLA (n = 3) experiments showing no
significant difference in KV1.2, KV1.5, KVβ1 and KVβ2 colocalizations in between coronary or mesenteric myocytes.
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Ablation of KVβ1.1 did not significantly impact hypoxia induced vasodilation
Hypoxia occurs when O2 saturation drops below 20% and induces the vasodilatory
response. Based on the different responses observed in KVβ1-/- and KVβ2-/- arteries, we
proposed that hypoxia induced vasodilation response would be abolished in the absence
of the KVβ2 subunit. Using the knockout mice, described above, we examined the effect
of KVβ-subunit ablation on the hypoxia response in coronary arteries. Representative
traces (Figure 8 A) show dilation in response to hypoxia in KVβ1-/- and their respective
wildtype. However, in Figure 8 (C) hypoxia induced dilation does not occur in KVβ2-/arteries, but it does in the respective wildtype. These experiments are graphically
summarized in Figure 8 (B, D).
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Figure 8. Ablation of KVβ2 not KVβ1.1 significantly diminishes hypoxia induced vasodilation. (A) Representative
myography trace of hypoxia induced vasodilation in arteries from WT (left, black) and KVβ1.1-/- (right, blue) mice. (B)
Summary graph of hypoxia induced dilation in WT and KVβ1.1-/- arteries, respectively (P-value >0.5). (C) Ablation of KVβ2
(right, red) significantly abolished hypoxia induced vasodilation as compared to wildtype (grey, left). (D) Summary graph of
hypoxia induced dilation in wildtype and KVβ2-/-.
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KVβ2 catalytic function is necessary for lactate induced vasodilation
The KVβ subunits are members of the aldo-keto reductase (AKR) family and is
important in the reduction of carbonyls. The KVβ2 subunit retains pyridine nucleotide
binding pockets that are conserved throughout the AKR family.95 The point mutation of the
KVβ2 subunit at the tyrosine in the 90th position to a phenylalanine abolishes the acid-base
catalytic functionality of the subunit.122 The Y90F point mutation abolishes the KVβ2
mediated lactate induced vasodilation response Figure 9 (A).
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Figure 9. Catalytically inactive KVβ2 point mutant (KVβ2Y90F) abolishes lactate induced vasodilation. (A)
Representative trace of arterial diameter from mesenteric arteries from wild type and KVβ2Y90F mice in the presence of
lactate (5-20 mM) and passive dilation in the presence of Ca2+ free PSS with 1uM nifedipine and 500 nM forskolin (n = 5
and 4, respectively). (B) Summary graph of percent (%) change in diameter comparing wildtype and KVβ2Y90F dilation to Llactate (5-20 mM) (* = P-value < 0.05).
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Figure 10. KV1 mediated vasodilation in response to elevated L-lactate requires catalytically functional KVβ2. (A)
Increased lactate is converted to pyruvate and NADH+ (B) via the lactate dehydrogenase enzyme. (C) In the absence of
KVβ2 (green), the KVβ1 (yellow) subunit predominates and in the presence of lactate and vasoconstriction occurs. (D) The
catalytically inactive KVβY90F (blue) abolishes lactate induced vasodilation. (E) Catalytically functional KVβ2 (green) is
required for arterial dilation in response to the vasodilator lactate.
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DISCUSSION

Here we have identified the Kvβ proteins as functional regulators of vascular tone
and further implicate divergent functional roles for Kvβ1 and Kvβ2 in the regulation of
metabolic coronary hyperemia. The following key findings support these conclusions: 1)
resistance arteries from Kvβ-null (Kvβ1.1-/-, Kvβ2-/-) mice exhibit normal vasoreactivity to
increases in intravascular pressure, elevated external K+, and thromboxane receptor
agonism; 2) vasodilation in response to L-lactate is abolished upon treatment with Kv1selective inhibitors and point mutation to or genetic ablation of Kvβ2 (KVβ2Y90F and KVβ2-/, respectively), but not Kvβ1.1 proteins; and 3) that the KVβ-subunits function similarly in
varying resistance vasculature beds (e.g., mesenteric and coronary) (Figure 10). Thus,
our results collectively support the concept that the predominant Kv1 auxiliary subunits,
Kvβ1.1 and Kvβ2, function to cooperatively control vasodilation upon changes in metabolic
demand.
Kvβ proteins of the AKR6 family of aldo-keto reductases are catalytically active
hydrophilic proteins that form heterotetrameric complexes at the cytosolic domain of native
voltage-gated potassium channels in excitable cell types throughout the cardiovascular,
nervous, endocrine, and immune systems.114 By the non-selective binding of a wide range
of carbonyl substrates, these proteins catalyze the NAD(P)H-dependent reduction of a
variety of endogenous aldehydes and ketones to primary and secondary alcohols.139,156
Through differential regulation of channel activation and inactivation properties as a
function of pyridine nucleotide redox status115, these proteins may participate in numerous
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physiological processes by coupling outward K+ current and membrane excitability with
intermediary metabolism.126 Despite nearly two decades of research on these intriguing
proteins, further experimentation is necessary to fully elucidate how distinct Kvβ proteins
perform unique and cell-specific roles in different organ systems.
The tight regulation of blood flow is crucial to ensure blood pressure, and organ
perfusion are maintained. Here, we report a physiologically relevant mechanism of
vasodilatory control in small resistance arteries mediated via the KV1 channel β-subunit
complex composition in response to altered metabolic demand that shifts substrates (e.g.,
NADH etc.) redox ratio.115 Our data demonstrate that the KV1-KVβ-subunit complex is
sensitive to lactate, which in turn induces a physiological response i.e., vasodilation. This
effect is abolished in the absence of the KVβ2 subunit or with loss of its catalytic function
(KVβ2Y90F). Additionally, our present work demonstrates that vasoconstriction (e.g., 60 mM
K+, and myogenic tone development) are not affected by changes to the KVβ-subunit
complex composition. Moreover, our data establish that lactate-induced vasodilation is a
response that acts independent of endothelial function and requires changes in the
vascular smooth muscle cell membrane potential. My data show that the KVβ2 subunit
mediating KV1 directed vasodilation.
Voltage-gated K+ channels expressed in excitable cells assemble as heteromeric
structures, with mixed compositions of pore-forming Kv1.x α subunits forming functional
channels with varied auxiliary subunit complexes. This ‘mix-and-match’ capability of Kv
channels may contribute to the considerable heterogeneity of K+ currents that enable
diverse physiological functions across a range of cell types. While our previous work found
that Kv1.5 channels in murine coronary arterial myocytes interact with Kvβ1.1/Kvβ2
heteromers,143 a key finding of the current study is the divergent functional regulation of
vascular tone by these proteins. Ablation of only Kvβ2 suppressed vasodilatory function,
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while ablation of Kvβ1.1 had little impact on vasodilation. These findings thus lead to the
question of the specific physiological role of Kvβ1.1 in the vasculature. Our data suggest
that the function of Kvβ2 is predominant. While the reasons for this discrepancy require
further inquiry, previous work has shown that Kvβ2 can inhibit the N-terminal inactivation
function of Kvβ1,130 either by competing for binding with pore-forming Shaker subunits, or
through biophysical modification of Kvβ1 function via Kvβ-β interactions. It should also be
noted that although Kvβ-subunit proteins are expressed in native Kv1 channels in the
vasculature, we cannot infer absolute subunit ratios in native Kv1 populations from our
data. Thus, considering that these proteins are present in Kv1 channels in smooth muscle
cells of wild type mice under normal conditions, it is plausible that the prevalence of Kvβ2
in Kv1 channels underlies the predominance of its functional importance under
physiological conditions. Nonetheless, our data also support the notion that conditions that
promote adaptive K+ channel remodeling towards elevated functional expression of
Kvβ1.1:Kvβ2 may likely have profound effects on vascular reactivity and blood flow
regulation.
Although our study indicates the involvement of Kvβ proteins in the regulation of
vasodilation, the upstream endogenous signals that contribute to this phenomenon are
unclear. Intriguingly, the Kvβ proteins were discovered as members of the aldo-keto
reductase superfamily of oxidoreductases and are functional enzymes that catalyze the
reduction of carbonyl compounds to alcohols.104,122 Hence, the Kvβ proteins each consist
of a conserved AKR active site with nucleotide binding domain for nicotinamide cofactor
hydride transfer. Later studies from our group and others demonstrating that the redox
state of bound pyridine nucleotide differentially modifies channel activation and
inactivation properties lead to the proposal that the Kvβs might serve as a critical link
between cellular metabolic state and membrane excitability to control diverse functions in
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excitable cells types.125,126,200 Based on the results of these studies and data presented
here, further studies are needed to determine whether changes in pyridine nucleotide
redox status in arterial myocytes underlie Kvβ-mediated control of blood flow in the heart
upon changes in metabolic demand.
Based on the data presented here we can conclude that: 1) lactate induced
vasodilation is mediated by the KV1 channel and requires the catalytically functional KVβ2
subunit; 2) ablation of either KVβ-subunit does not impact pressure induced myogenic tone
development; 3) ablation of either subunit does not significantly impair the vasoconstrictor
response to membrane depolarization or agonist induced constriction; 4) neither KVβ1 or
KVβ2 appear to enhance or impair adenosine induced vasodilation; 5) lactate induced
vasodilation is mediated independent of the endothelium; 6) overexpression of the Kvβ1
subunit emulates the Kvβ2-/- condition; 7) coronary and mesenteric myocyte KV-channels
have similar quantities of colocalized KV-α and KV-β components. These data support
crucial functional roles for KVβ1 and Kvβ2 in modifying KV1 mediated arterial diameter in
response to vasodilators. I have also provided evidence for the KVβ2 subunit, and its
catalytic activity, as a sensor of altered metabolic demand that alters KV1 mediated
vasodilation. Additionally, recently acquired unpublished data using electrophysiological
patch clamp, conducted by graduate student Marc Dwenger, shows whole cell outward
potassium currents increase significantly in the presence of lactate, and this is inhibited in
the presence of Psora-4. Altogether, these data support a functional role for KVβ2 as a
sensor, triggered by altered metabolic demand, that modifies KV1 mediated vasodilation.
The present study has several key limitations. One limitation is potential sex-based
differences that may exist and differently affect the phenomenon we observe.201,202 To
address this, future studies will conduct many of these experiments in age matched female
mice to determine any potential sex-based differences. Additionally, the use of global
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knockout murine models presents potential issues in other organ systems which may
impact the resultant observed phenomenon. To address this issue, I will use tissuespecific doxycycline inducible expression models, as described in the materials and
methods section. When these mice are given water containing doxycycline (ad libitum) for
ten days the reverse tetracycline trans-activator, driven by the SM22α promoter, increases
smooth muscle specific expression of the associated β-subunit. Using these models
should mitigate any affects observed in the global KVβ-knockout murine models.
Additionally, the effects of aging on the cardiovascular system are not well understood
and could result in a variable response to the phenomenon observed. To address this,
future studies will compare differences in KVβ subunit expression and function in mice of
different age categories (e.g., young versus old).
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